Scarica l'app Stockscreener
2.33
4.72%
0.105
Dopo l'orario di chiusura:
2.26
-0.07
-3.00%
Precedente Chiudi:
$2.225
Aprire:
$2.18
Volume 24 ore:
131.64K
Relative Volume:
0.13
Capitalizzazione di mercato:
$52.39M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-4.7551
EPS:
-0.49
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
+4.95%
1M Prestazione:
-20.75%
6M Prestazione:
-23.61%
1 anno Prestazione:
+36.90%
Intervallo 1D:
$2.16
$2.498
Intervallo di 1 settimana:
$2.16
$2.498
Portata 52W:
$1.30
$7.97
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
2.33 | 52.39M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
CELUCelularity Inc. Latest Stock News & Market Updates - StockTitan
Celularity announces resolution of Nasdaq listing compliance matter - Nasdaq
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times
Celularity Restores Nasdaq Compliance After Major Financial Reporting Overhaul - StockTitan
Celularity reports Q3 EPS (73c) vs. ($4.98) last year - MSN
Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145% - Nasdaq
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - The Manila Times
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third - EIN News
Celularity Inc. (CELU) reports earnings - Quartzy
Celularity Reports Explosive 621% Product Sales Growth, Returns to Nasdaq Compliance - StockTitan
Celularity Inc. announced that it expects to receive $1 million in funding - Marketscreener.com
Celularity Inc faces Nasdaq delisting over late filing By Investing.com - Investing.com South Africa
Celularity Inc faces Nasdaq delisting over late filing - Investing.com
Celularity Inc. Announces Receipt of Nasdaq Notification - The Manila Times
Celularity announces receipt of Nasdaq notification - MSN
Celularity faces Nasdaq delisting over filing delay - Investing.com India
Celularity Faces Nasdaq Non-Compliance Notice Over Delayed Q3 Filing | CELU Stock News - StockTitan
Genting breaks ground on stem cell facility in Bali, Indonesia - theSun
Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific - The Manila Times
Celularity Partners with Genting to Build $7.2B Market-Targeting Stem Cell Facility in Bali | CELU Stock News - StockTitan
Celularity Resolves Nasdaq Compliance Issue, Maintains Listing After Filing Reports | CELU Stock News - StockTitan
Celularity Inc. (NASDAQ:CELU) Sees Large Increase in Short Interest - MarketBeat
After-Market Momentum: Celularity (CELU) Shares Climb On Increased Guidance - Stocks Telegraph
Celularity sets annual meeting date, stockholder proposal deadline By Investing.com - Investing.com Canada
Celularity sets annual meeting date, stockholder proposal deadline - Investing.com India
Celularity Inc. (CELU) Quarterly 10-Q Report - Quartzy
Celularity Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
U.S. Stock market: Celularity(+52.68%), Applovin(+45.14%), FARO Technologies(+33.01%) and others were among the top gainers during mid day trading - Business Upturn
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million - The Manila Times
Celularity Raises 2024 Sales Forecast to $60M After Record-Breaking October Revenue | CELU Stock News - StockTitan
CELU stock touches 52-week low at $1.55 amid market fluctuations - Investing.com India
CELU stock touches 52-week low at $1.55 amid market fluctuations By Investing.com - Investing.com South Africa
Celularity reports over $24 million in biomaterial revenue By Investing.com - Investing.com Australia
Celularity Inc. Announces Anticipated Revenues for Second and Third Quarters - Defense World
Celularity reports over $24 million in biomaterial revenue - Investing.com India
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - The Manila Times
Celularity reports progress on Nasdaq compliance and product sales - Investing.com
Celularity reports progress on Nasdaq compliance and product sales By Investing.com - Investing.com Australia
Celularity Provides Corporate Update - citybiz
CELUWCelularity Inc. Warrant Latest Stock News & Market Updates - StockTitan
Celularity to submit 510(k) notification for Tendon Wrap in early 2025 - TipRanks
Celularity faces Nasdaq delisting over reporting delays - Investing.com
Celularity faces Nasdaq delisting over reporting delays By Investing.com - Investing.com UK
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):